The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

In a recent panel conversation, healthcare and industry experts discussed where to find reliable guidance in a sea of ...

For many years, health experts have been concerned about "food deserts," places where residents lack good nutritional options. Now, an MIT-led study of three major global cities uses a new, granular ...

After menopause, individuals with cardiovascular disease and weight gain may face a higher risk of breast cancer, recent ...

Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...

A new federal estimate shows a rise in prediabetes among American adolescents, a finding that is spurring concerns about the ...

Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...

Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...

Researchers conducted the REDEFINE 1 and REDEFINE 2 clinical trials to assess the effect of CagriSema on weight loss in obesity with or without type 2 diabetes.

Researchers conducted a post hoc analysis of the SURMOUNT-1 trial to assess the effect of tirzepatide on kidney function in prediabetes with obesity or overweight.

Dr Joseph A Hill discusses the diagnosis and management of heart failure with preserved ejection fraction (HFpEF).